Skip to content

FEED

ENvue Medical, Inc.

NASDAQ · Healthcare · Medical - Specialties · US

$1.03
+0.00%
Ask drillr

Year over year

Reported trailing growth

Revenue
-17.7%
EBITDA
-75.5%
EBIT
-84.8%
EPS
—
Free cash flow
—
Operating cash flow
—

Forward estimates

Based on analyst estimates

Revenue
—
EBITDA
—
EPS
—

Three-year CAGR

Revenue
+50.3%
EBITDA
—
EBIT
—
Net income
—
EPS
+85.8%
Free cash flow
—

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026